Avoidance of CYP2D6 inhibitors in patients receiving tamoxifen

Roberta Ferraldeschi, Sacha J. Howell, Alastair M. Thompson, William G. Newman

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e584-e585
Journal	Journal of Clinical Oncology
Volume	28
Issue number	29
DOIs	https://doi.org/10.1200/JCO.2010.30.1887
Publication status	Published - 10 Oct 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{2d090eefb25b42b59c06a57ffa6d3d8b,

title = "Avoidance of CYP2D6 inhibitors in patients receiving tamoxifen",

author = "Roberta Ferraldeschi and Howell, {Sacha J.} and Thompson, {Alastair M.} and Newman, {William G.}",

year = "2010",

month = oct,

day = "10",

doi = "10.1200/JCO.2010.30.1887",

language = "English",

volume = "28",

pages = "e584--e585",

journal = "Journal of Clinical Oncology",

issn = "1527-7755",

publisher = "Lippincott Williams & Wilkins",

number = "29",

}

TY - JOUR

T1 - Avoidance of CYP2D6 inhibitors in patients receiving tamoxifen

AU - Ferraldeschi, Roberta

AU - Howell, Sacha J.

AU - Thompson, Alastair M.

AU - Newman, William G.

PY - 2010/10/10

Y1 - 2010/10/10

U2 - 10.1200/JCO.2010.30.1887

DO - 10.1200/JCO.2010.30.1887

M3 - Letter

SN - 1527-7755

VL - 28

SP - e584-e585

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 29

ER -